The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through September 2025.
Under the contracts, the prime contractor will leverage large-scale U.S. healthcare data as the primary source, including administrative claims data and electronic health records, to support the FDA's post-market surveillance of biologics. Specifically, the aim is to obtain new data sources covering tens of millions of patients directly from insurers, payers or providers. Data must be accessible through a distributed network potentially using the OMOP common data model, with full medical charts reviewable for biologics surveillance activities. The original solicitation sought these data sources to advance the FDA Center for Biologics Evaluation and Research's Biologics Effectiveness and Safety Initiative #3 through the multiple IDIQ contracts.
Generated 1/4/24, 10:08 PM